Home » Behavioural Investing » Facebook avoids death of thousand cuts. Still needs one big bandage. $FB

Facebook avoids death of thousand cuts. Still needs one big bandage. $FB

Image representing Facebook as depicted in Cru...

Image via CrunchBase

Facebook (Nasdaq:FB) has drawn criticism by allowing insiders who control some one billion shares to sell now instead of later. Facebook valuation is controversial no lets say dubious. The overhang would always be a negative black cloud. Delaying the inevitable sell action would just perpetuate the death of a thousand cuts.

Open up the doors. Let the blood flow and get it over with. Investors knew this was coming so it should have been baked into the valuations. Or maybe it wasn’t and investors who got it wrong are just engaging in scream therapy and dealing with their angst.

George Gutowski writes from a caveat emptor perspective. Follow him on twitter@financialskepti

Advertisements